The Expected Blood Glucose Reduction from 4 Units of Actrapid
There is no fixed, predictable amount by which 4 units of Actrapid (regular insulin) will reduce blood glucose—the response varies significantly based on individual insulin sensitivity, current glucose level, body weight, and clinical context.
Understanding Insulin Sensitivity and Correction Doses
The glucose-lowering effect of insulin is highly individualized and depends on the patient's insulin sensitivity factor (ISF), which varies widely between patients. According to hospitalized patient protocols, correction dose scales are stratified by insulin sensitivity 1:
Correction Insulin Scales for Hospitalized Patients
For blood glucose 141-180 mg/dL (7.8-10.0 mmol/L), the recommended correction dose is 1:
- Insulin-sensitive patients: 2 units
- Usual sensitivity patients: 4 units
- Insulin-resistant patients: 6 units
This demonstrates that 4 units represents a "usual" correction dose for mild hyperglycemia in average-sensitivity patients, but the same 4 units would be excessive for insulin-sensitive patients and insufficient for insulin-resistant patients.
Estimating Individual Insulin Sensitivity
The "1500 Rule" or "1800 Rule" can estimate how much 1 unit of regular insulin lowers glucose:
- Divide 1500 (or 1800 for more conservative estimates) by the total daily insulin dose
- Example: If a patient uses 50 units/day total, 1 unit drops glucose by approximately 30-36 mg/dL (1.7-2.0 mmol/L)
- Therefore, 4 units would lower glucose by approximately 120-144 mg/dL (6.7-8.0 mmol/L) in this example
However, this calculation only applies to patients already on established insulin therapy and varies with:
- Body weight: Heavier patients require more insulin per unit of glucose reduction
- Current glucose level: Higher glucose levels may show greater absolute reductions
- Insulin resistance: Conditions like obesity, infection, or steroid use reduce insulin effectiveness
- Renal function: Impaired kidney function prolongs insulin action and increases hypoglycemia risk
Clinical Context Matters
In Hospitalized Patients
Guidelines recommend starting correction doses conservatively 1, 2:
- Insulin-sensitive column (including elderly, renal impairment, NPO patients): Start with 2 units for glucose 141-180 mg/dL
- Insulin-resistant column (corticosteroid use, >80 units/day at home): May need 6 units for the same glucose range
In Outpatient Initiation
When adding prandial insulin to basal therapy 3:
- Initial prandial doses typically start at 4 units per meal or 10% of basal dose
- This is a starting point for titration, not based on expected glucose reduction
Critical Safety Considerations
The most important clinical principle is avoiding hypoglycemia, which carries significant morbidity and mortality risk 2, 4:
- Never use fixed correction doses without considering individual factors
- In elderly patients (≥70 years) or those with renal impairment (GFR <60 mL/min), starting insulin doses should be reduced to 0.2-0.3 U/kg/day total 1
- For hypoglycemia without clear cause, reduce insulin doses by 10-20% 3
Monitoring Requirements
When using correction insulin 1:
- Monitor glucose every 4-6 hours with regular insulin
- Adjust subsequent doses based on response, not predetermined expectations
- Use the insulin-sensitive scale for high-risk patients until individual response is established
Practical Algorithm for Correction Dosing
To determine appropriate correction insulin:
Assess insulin sensitivity category 1:
- Sensitive: Elderly, renal impairment, NPO, insulin-naive
- Usual: Most hospitalized patients with diabetes
- Resistant: On corticosteroids, >80 units/day at home, severe obesity
Use appropriate correction scale based on current glucose and sensitivity category 1
Monitor response at 4-6 hours for regular insulin (2-4 hours for rapid-acting analogs)
Adjust subsequent doses based on observed response, not theoretical calculations
The answer to "how much does 4 units reduce glucose" is therefore: "It depends entirely on the individual patient's insulin sensitivity, which must be determined through careful monitoring and dose titration rather than assumed from a fixed formula."